A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD)

NCT00216489 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

191

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroesophageal Reflux
Heartburn

Interventions

DRUG: rabeprazole sodium

Sponsor

Janssen Cilag Pharmaceutica S.A.C.I., Greece